MENU
FDMT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

4D Molecular Therapeutics (FDMT) Ownership - Who owns 4D Molecular Therapeutics?

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors... Show more

Profile

Industry
N/A
Address
5858 Horton Street
Phone
+1 510 505-2680
Employees
147
Web
https://www.4dmoleculartherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
462.79M
P/E Ratio
N/A
Total Cash
305.06M
Projected Growth
N/A
Total Debt
22.26M
Revenue
120K
Risk (Beta)
3.28
Dividend Yield
N/A
Total Cash/Share
5.34
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price

Fundamentals

FDMT
Capitalization
463M
P/E Ratio
N/A
Risk (Beta)
3.28
Dividend Yield
N/A
Total Cash
305M
Total Cash/Share
5.34
Total Debt
22.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
120K
ROE
N/A
Book Value
369M
P/B Ratio
1.25
Cash Flow
N/A
Earnings
-3.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
8.42
Current Revenue Per Employee
396.48
Dividends Per Share - Security
N/A
EBITDA
-222.95M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.70
Shares Held By Institutions
515M
Shares Outstanding - Current
57.1M
Total Liabilities
55M
Total Volume MTD
N/A
Value
-1
Gain YTD
45.422
View a ticker or compare two or three
FDMT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FDMT showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
5858 Horton Street
Phone
+1 510 505-2680
Employees
147
Web
https://www.4dmoleculartherapeutics.com